EA 3847, Faculté de Chirurgie Dentaire, Université d'Auvergne, 63000 Clermont-Ferrand, France Inserm U 929, Clermont-Ferrand, France Centre de Pharmacologie Clinique, CHU, Clermont-Ferrand, France Département d'Information Médicale, CHU, Clermont-Ferrand, France CHU, Clermont-Ferrand, Hôtel-Dieu, F-63001 Clermont-Ferrand, France.
Pain. 2010 Apr;149(1):27-32. doi: 10.1016/j.pain.2009.11.016. Epub 2010 Jan 18.
Burning mouth syndrome (stomatodynia) is associated with changes of a neuropathic nature the main location of which, peripheral or central, remains unknown. A randomised, double-blind crossover design was used to investigate the effects of lingual nerve block on spontaneous burning pain and a possible correlation with the effects of topical clonazepam, the patient's response to a psychological questionnaire, and the taste and heat thresholds. The spontaneous burning was measured with a visual analogue scale (VAS) just before and 15 min after injection. The decreases in VAS score after lidocaine or saline injection were not significantly different (2.7+/-3.9 and 2.0+/-2.6, respectively; n=20). However, two groups of patients could be identified: in a "peripheral group" (n=10) the VAS decrease due to lingual nerve injection was 4.3+/-3.1cm after lidocaine and 0.9+/-0.3 cm after saline (p=0.02). In a "central group" (n=7), there were an increase in pain intensity score (-0.8+/-2.6 cm) after lidocaine and a decrease (1.5+/-3.0 cm) after saline (p=0.15). An increase in the hospital anxiety and depression (HAD) score and a decreased taste sensitivity and heat pain threshold of painful oral area were seen in patients compared with age-and-sex-matched controls (p<0.05). Topical clonazepam treatment tended to be more effective (p=0.07) and HAD score lower (p<0.03) in the peripheral than in the central group. These results suggest that the neuropathic disorder associated with stomatodynia may be predominantly peripheral, central or mixed depending on the individual. Topical application of clonazepam and HAD may serve as indicators of which mechanism is dominating.
灼口综合征(口腔痛)与神经病理性改变有关,其主要部位(外周或中枢)尚不清楚。本研究采用随机、双盲交叉设计,旨在探讨舌神经阻滞对自发性灼痛的影响,以及与局部氯硝西泮的疗效、患者对心理问卷的反应、味觉和热阈值之间的可能相关性。注射前和注射后 15 分钟,采用视觉模拟量表(VAS)测量自发性灼痛。利多卡因或生理盐水注射后 VAS 评分的下降无显著差异(分别为 2.7+/-3.9 和 2.0+/-2.6,n=20)。然而,可将患者分为两组:在“外周组”(n=10)中,舌神经注射后 VAS 下降 4.3+/-3.1cm 利多卡因和 0.9+/-0.3cm 生理盐水(p=0.02)。在“中枢组”(n=7)中,利多卡因注射后疼痛强度评分增加(-0.8+/-2.6cm),生理盐水注射后下降(1.5+/-3.0cm)(p=0.15)。与年龄和性别匹配的对照组相比,患者的医院焦虑和抑郁量表(HAD)评分升高,味觉敏感性和疼痛口腔区域的热痛阈值降低(p<0.05)。与中枢组相比,局部应用氯硝西泮治疗更有效(p=0.07),HAD 评分更低(p<0.03)。这些结果表明,灼口综合征相关的神经病理性障碍可能主要是外周性、中枢性或混合性的,取决于个体。局部应用氯硝西泮和 HAD 可能作为哪种机制占主导地位的指标。